UK Markets close in 7 hrs 53 mins

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
44.41-1.84 (-3.98%)
At close: 04:00PM EDT
44.88 +0.47 (+1.06%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3133.82
52-week low 327.65
50-day moving average 345.75
200-day moving average 378.61

Share statistics

Avg vol (3-month) 31.5M
Avg vol (10-day) 31.46M
Shares outstanding 5101.66M
Implied shares outstanding 6N/A
Float 892.03M
% held by insiders 14.71%
% held by institutions 194.93%
Shares short (28 Apr 2022) 43.91M
Short ratio (28 Apr 2022) 44.34
Short % of float (28 Apr 2022) 45.20%
Short % of shares outstanding (28 Apr 2022) 43.84%
Shares short (prior month 30 Mar 2022) 43.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin -108.57%
Operating margin (ttm)-110.00%

Management effectiveness

Return on assets (ttm)-11.48%
Return on equity (ttm)-38.46%

Income statement

Revenue (ttm)373.65M
Revenue per share (ttm)3.69
Quarterly revenue growth (yoy)38.00%
Gross profit (ttm)250.74M
EBITDA -388.73M
Net income avi to common (ttm)-405.67M
Diluted EPS (ttm)-4.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)932.75M
Total cash per share (mrq)9.16
Total debt (mrq)1.37B
Total debt/equity (mrq)212.98
Current ratio (mrq)5.72
Book value per share (mrq)6.98

Cash flow statement

Operating cash flow (ttm)-209.02M
Levered free cash flow (ttm)-123.48M